Annual CFI
$15.56 M
-$17.07 M-52.32%
December 31, 2023
Summary
- As of February 6, 2025, KURA annual cash flow from investing activities is $15.56 million, with the most recent change of -$17.07 million (-52.32%) on December 31, 2023.
- During the last 3 years, KURA annual CFI has risen by +$115.49 million (+115.57%).
- KURA annual CFI is now -52.32% below its all-time high of $32.63 million, reached on December 31, 2022.
Performance
KURA Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$45.53 M
+$2.37 M+5.49%
September 30, 2024
Summary
- As of February 6, 2025, KURA quarterly cash flow from investing activities is $45.53 million, with the most recent change of +$2.37 million (+5.49%) on September 30, 2024.
- Over the past year, KURA quarterly CFI has increased by +$3.34 million (+7.92%).
- KURA quarterly CFI is now -38.52% below its all-time high of $74.06 million, reached on December 31, 2021.
Performance
KURA Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$35.56 M
+$36.98 M+2611.30%
September 30, 2024
Summary
- As of February 6, 2025, KURA TTM cash flow from investing activities is $35.56 million, with the most recent change of +$36.98 million (+2611.30%) on September 30, 2024.
- Over the past year, KURA TTM CFI has increased by +$20.00 million (+128.58%).
- KURA TTM CFI is now -76.91% below its all-time high of $154.01 million, reached on September 30, 2022.
Performance
KURA TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
KURA Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.3% | +7.9% | +128.6% |
| 3 y3 years | +115.6% | +7.9% | +128.6% |
| 5 y5 years | +119.6% | +7.9% | +128.6% |
KURA Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -52.3% | +112.3% | -38.5% | +147.8% | -76.9% | +128.0% |
| 5 y | 5-year | -52.3% | +112.3% | -38.5% | +124.5% | -76.9% | +110.8% |
| alltime | all time | -52.3% | +112.3% | -38.5% | +124.5% | -76.9% | +110.8% |
Kura Oncology Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $45.53 M(+5.5%) | $35.56 M(-2611.3%) |
| Jun 2024 | - | $43.17 M(-145.3%) | -$1.42 M(-98.4%) |
| Mar 2024 | - | -$95.34 M(-325.9%) | -$90.91 M(-684.4%) |
| Dec 2023 | $15.56 M(-52.3%) | $42.20 M(+393.0%) | $15.56 M(-121.0%) |
| Sep 2023 | - | $8.56 M(-118.5%) | -$73.96 M(+590.9%) |
| Jun 2023 | - | -$46.33 M(-516.3%) | -$10.71 M(-115.6%) |
| Mar 2023 | - | $11.13 M(-123.5%) | $68.72 M(+110.6%) |
| Dec 2022 | $32.63 M(-125.7%) | -$47.32 M(-165.9%) | $32.63 M(-78.8%) |
| Sep 2022 | - | $71.81 M(+117.0%) | $154.01 M(+47.0%) |
| Jun 2022 | - | $33.10 M(-232.6%) | $104.74 M(+204.3%) |
| Mar 2022 | - | -$24.96 M(-133.7%) | $34.42 M(-127.1%) |
| Dec 2021 | -$126.83 M(+26.9%) | $74.06 M(+228.5%) | -$126.83 M(-51.4%) |
| Sep 2021 | - | $22.55 M(-160.6%) | -$261.09 M(-20.7%) |
| Jun 2021 | - | -$37.22 M(-80.0%) | -$329.15 M(+5.0%) |
| Mar 2021 | - | -$186.22 M(+209.4%) | -$313.62 M(+213.8%) |
| Dec 2020 | -$99.94 M(+115.7%) | -$60.19 M(+32.2%) | -$99.94 M(+81.7%) |
| Sep 2020 | - | -$45.52 M(+109.9%) | -$55.00 M(-15.7%) |
| Jun 2020 | - | -$21.69 M(-179.0%) | -$65.23 M(+88.1%) |
| Mar 2020 | - | $27.46 M(-280.0%) | -$34.67 M(-25.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$46.33 M(-41.6%) | -$15.26 M(-72.6%) | -$46.33 M(+75.1%) |
| Sep 2019 | - | -$55.75 M(-728.1%) | -$26.45 M(-8.0%) |
| Jun 2019 | - | $8.88 M(-43.9%) | -$28.76 M(-14.9%) |
| Mar 2019 | - | $15.81 M(+242.3%) | -$33.78 M(-57.4%) |
| Dec 2018 | -$79.30 M(+238.6%) | $4.62 M(-108.0%) | -$79.30 M(-9.9%) |
| Sep 2018 | - | -$58.06 M(-1605.3%) | -$88.01 M(+32.9%) |
| Jun 2018 | - | $3.86 M(-113.0%) | -$66.24 M(+5.7%) |
| Mar 2018 | - | -$29.71 M(+626.3%) | -$62.67 M(+167.6%) |
| Dec 2017 | -$23.42 M(-292.3%) | -$4.09 M(-88.7%) | -$23.42 M(+142.7%) |
| Sep 2017 | - | -$36.29 M(-588.3%) | -$9.65 M(-136.0%) |
| Jun 2017 | - | $7.43 M(-22.0%) | $26.79 M(+98.2%) |
| Mar 2017 | - | $9.53 M(-1.5%) | $13.52 M(+11.0%) |
| Dec 2016 | $12.18 M(-117.2%) | $9.68 M(+6669.2%) | $12.18 M(-132.1%) |
| Sep 2016 | - | $143.00 K(-102.4%) | -$37.95 M(-9.6%) |
| Jun 2016 | - | -$5.84 M(-171.3%) | -$41.98 M(-32.7%) |
| Mar 2016 | - | $8.20 M(-120.3%) | -$62.42 M(-11.6%) |
| Dec 2015 | -$70.63 M | -$40.45 M(+939.5%) | -$70.63 M(+134.0%) |
| Sep 2015 | - | -$3.89 M(-85.2%) | -$30.18 M(+14.8%) |
| Jun 2015 | - | -$26.28 M(>+9900.0%) | -$26.29 M(>+9900.0%) |
| Mar 2015 | - | -$10.00 K | -$10.00 K |
FAQ
- What is Kura Oncology annual cash flow from investing activities?
- What is the all time high annual CFI for Kura Oncology?
- What is Kura Oncology annual CFI year-on-year change?
- What is Kura Oncology quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Kura Oncology?
- What is Kura Oncology quarterly CFI year-on-year change?
- What is Kura Oncology TTM cash flow from investing activities?
- What is the all time high TTM CFI for Kura Oncology?
- What is Kura Oncology TTM CFI year-on-year change?
What is Kura Oncology annual cash flow from investing activities?
The current annual CFI of KURA is $15.56 M
What is the all time high annual CFI for Kura Oncology?
Kura Oncology all-time high annual cash flow from investing activities is $32.63 M
What is Kura Oncology annual CFI year-on-year change?
Over the past year, KURA annual cash flow from investing activities has changed by -$17.07 M (-52.32%)
What is Kura Oncology quarterly cash flow from investing activities?
The current quarterly CFI of KURA is $45.53 M
What is the all time high quarterly CFI for Kura Oncology?
Kura Oncology all-time high quarterly cash flow from investing activities is $74.06 M
What is Kura Oncology quarterly CFI year-on-year change?
Over the past year, KURA quarterly cash flow from investing activities has changed by +$3.34 M (+7.92%)
What is Kura Oncology TTM cash flow from investing activities?
The current TTM CFI of KURA is $35.56 M
What is the all time high TTM CFI for Kura Oncology?
Kura Oncology all-time high TTM cash flow from investing activities is $154.01 M
What is Kura Oncology TTM CFI year-on-year change?
Over the past year, KURA TTM cash flow from investing activities has changed by +$20.00 M (+128.58%)